Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease

ConclusionsOur data supports the notion that dysmetabolisms part of the ADPKD phenotype and associated with a poor outcome, especially in patients with a truncatingPKD1 mutation.

http://link.springer.com/10.1007/s10157-019-01748-z

Source: Clinical and Experimental Nephrology - May 26, 2019 Category: Urology & Nephrology Source Type: research